Lexicon drug shows cardiac and platelet effects in preclinical studies
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- S&P 500, Nasdaq end sharply lower as revived AI doubts ignite tech selloff
- Meta’s new Class C stock to keep Zuckerberg in California, fund AI spending spree
- Oil hits five-month high as Houthi attacks stoke supply fears
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
| Lexicon Pharmaceuticals, Inc. (NASDAQ: LXRX) | Delayed: 1.49 -0.07 (4.49%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.56 | 52 Week High | $19.62 | |||
| Open | $1.56 | 52 Week Low | $7.65 | |||
| Day High | $1.59 | P/E | N/A | |||
| Day Low | $1.49 | EPS | $-0.22 | |||
| Volume | 951,174 | |||||
